Concepedia

Bei Gao

BG

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2017

Affiliations

East China Normal University(Current)

Bei Gao is an author at East China Normal University specializing in monoclonal antibodies, serum half-life, and antibody discovery.

ORCID

Publications per year

2017–2024

3

Publications

3

FZ-AD005, a Novel DLL3-Targeted Antibody–Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models

Qingsong Guo, Bei Gao, Ruiwen Song et al. · Molecular Cancer Therapeutics · 2024 · 22 citations · Full text

, , +16

Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential

Yifan Zhang, Lei Wang, Xuemei Cao et al. · Journal of Medicinal Chemistry · 2024 · 18 citations

, , +17

Increased half-life and enhanced potency of Fc-modified human PCSK9 monoclonal antibodies in primates

Yijun Shen, Hua Li, Li Zhao et al. · PLoS ONE · 2017 · 17 citations · Full text

, , +17

1–3 of 3